Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Peristaltic Pump Delivers Unparalleled Flexibility in Fluid Transfer
Wednesday, April 16, 2014
Broad flow range, ergonomic, compact design easily integrates into space-constrained applications.

Efficient Delivery of Proteins into Living Cells
Tuesday, April 15, 2014
BioPORTER® protein delivery reagent from AMSBIO.

Vetter Launches New Clinical Syringe Packages
Friday, April 11, 2014
Earlier syringe development may cut time-to-market, increase clinical trial appeal.

High-Throughput Label-Free Interaction Analysis Made Easy with EzPlex
Friday, April 11, 2014
HORIBA Scientific announces the launch of EzPlex, the new flagship instrument of the label-free molecular interaction platform based on Surface Plasmon Resonance imaging (SPRi).

Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.

Grace Launches ProVance Disposable Protein A Chromatography Columns
Tuesday, April 08, 2014
Columns pre-packed with high-capacity silica resin improve drug purification productivity.

Seward Ramps Up Stomacher® Bag Manufacturing
Friday, April 04, 2014
Minimizing delivery lead times and environmental footprint for ISO 14001.

Bosch to Showcase Complete Systems Competence
Thursday, April 03, 2014
Module++ lines for high adaptability, versatility and easy automation.

Link’s New Modifier for Improved Oligo Delivery
Thursday, March 27, 2014
5’-Palmitate-C6-CE Phosphoramidite from Link Technologies.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 453
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv